270 articles
Go beyond the basics of parabiosis to explore the specific proteins, exosomes, and signaling pathways that make young blood rejuvenating — and old blood damaging.
How immune function changes with age, why chronic sterile inflammation reinforces that decline, which immune measurements are worth ordering in ordinary practice, and which interventions have real evidence behind them.
Discover how scientists joined the circulatory systems of young and old mice — and what it taught us about the surprising power of bloodstream factors to reverse signs of aging.
A clinical guide to protein and metabolite measurement — why these layers report present state rather than inherited risk, what broad panels can and cannot support, and how to judge an organ-age or metabolomic result you did not order.
A deep mechanistic investigation into how rapamycin and next-generation rapalogs modulate aging pathways — from allosteric binding kinetics to clinical trial design and emerging bi-steric inhibitors.
A clinical guide to interpreting biological-age and pace-of-aging results: what the epigenome is, what each generation of clock was trained to predict, why repeat testing of the same sample can differ by years, and how to counsel a patient who wants to buy one.
Go beyond the basics — explore the molecular machinery linking mTOR inhibition to lifespan extension, and what the latest research tells us about rapamycin's real-world potential.
The fourth-tier hallmarks — regenerative decline, altered tissue signaling, inflammaging and gut dysbiosis — are the ones that actually walk into clinic. How to measure them with a dynamometer, a hallway and a short lab panel, and which single prescription moves several at once.
Discover how a molecule found in Easter Island soil became one of science's most promising tools against aging — and what it means for your health.
The three aging processes that begin as protective responses and become drivers — what can actually be measured in clinic today, and where the human evidence for rapamycin, metformin, NAD precursors and senolytics genuinely stands.
A deep mechanistic exploration of how B12 deficiency reshapes the aging brain's epigenome, fuels neuroinflammation, and demands individualized correction strategies beyond standard dosing protocols.
A clinical read of the five upstream hallmarks — genomic instability, telomere attrition, epigenetic drift, loss of proteostasis and disabled autophagy — separating what is measurable in a patient from what is mechanism only, and what has human endpoint data from what does not.
